Differential blood-based diagnosis between benign prostatic hyperplasia and prostate cancer: miRNA as source for biomarkers independent of PSA level, Gleason score, or TNM status

Overview of attention for article published in Tumor Biology, January 2016

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 46 Dimensions

Readers on

mendeley: 69 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 53,468 followers.

Differential blood-based diagnosis between benign prostatic hyperplasia and prostate cancer #biomarkers https://t.co/Y1Oy4jbedH @drdrauzio https://t.co/LWy0TNhSPt

Reply Repost Favourite

Differential blood-based diagnosis between benign prostatic hyperplasia and prostate cancer: miRNA as source for… https://t.co/OEf0Vij9ts

Reply Repost Favourite